Embeddedadvisor
US
APAC
EUROPE
  • Home
  • Insights
  • Whitepaper
  • Conferences
  • Newsletter
  • Subscribe
  • News
  • About us
Go to...
  • Home
  • Insights
  • Whitepaper
  • Conferences
  • Newsletter
  • Subscribe
  • News
  • About us
  • Categories

  • IP Design
  • Telecom
  • Wearables and Sensor
  • Consumer Electronics
  • IoT
  • More
      • Industrial Computing
Go to...
  • Categories

  • IP Design
  • Telecom
  • Wearables/Sensor
  • Consumer Electronics
  • IoT
  • Industrial Computing
×
#

Embedded Advisor Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Embedded Advisor

Subscribe

loading

THANK YOU FOR SUBSCRIBING

  • Home
  • Medical Devices
  • Vendor
  • ANSYS [NASDAQ:ANSS]

ANSYS [NASDAQ:ANSS]: Modeling Human Body with Simulation Software

Thierry Marchal, Global Industry Director, ANSYS [NASDAQ:ANSS]Thierry Marchal, Global Industry Director
“Those who embrace true technological revolutions early on emerge as the market leaders,” states Thierry Marchal, Global Industry Director of ANSYS [NASDAQ:ANSS], in one of his articles ‘IN VIVO, IN VITRO, IN SILICO,’ published in the 9th volume of ANSYS Advantage. Justifiably, Marchal’s statement falls in line with the path taken by ANSYS toward the ingenious approach of simulating a part or whole of the human body through computational analysis for various medical applications. A stride such as this paves the way for accurate diagnostics, clinical experimentation, and lower risk of operations while complying with the safety and precautionary standards.

Leveraging simulation, ANSYS aims to advance the medical industry by reducing the time taken for processes like clinical diagnostics and testing of medical apparatus. The company collaborates with medical device manufacturers, clinicians, and hospitals to develop simulation software to model how medical devices interact with the human body and understand how it behaves under set constraints or operating conditions. Following the trail of medical sciences transcending from the traditional in-vivo approach to in-vitro testing methodologies, ANSYS leads the disruption that comes in the form of in-silico testing. The FDA backed technique employs the concept of performing computational analysis on the human body to observe the functioning of body parts, medical procedures, and drugs.

The company is fostering customization of medical practices in accordance with various medical conditions. As it may be difficult or sometimes impossible to find volunteers for some of the medical procedures and tests, computation analysis lowers the costs and risks associated with traditional practices.

The simulation software developed by ANSYS allows the user to replicate tissues, bones, and implanted devices using advanced modeling techniques that are previously validated through experimentation


The simulation software developed by ANSYS allows the user to replicate tissues, bones, and implanted devices using advanced modeling techniques that are previously validated through experimentation. This creates a virtual workbench for practitioners to operate upon without any associated risks. Medical device manufacturers can simulate how their new prototype would interact with a virtual patient on a computer and predict their behavior for different patients. Various complexities or abnormalities can be incorporated into simulation with more advanced and nonlinear models, obeying the natural functions of a human body. Once the simulation set-up is complete, practitioners can virtually test their equipment or processes to enhance their practices. Medical professionals can change the parameters governing the simulation or alter the operating conditions, and repeat the tests to learn multiple probabilities or outcomes of the operational procedures.

Owing to the fact that every human body is unique, simulations can be tailored to suit a particular condition or a specific type of body, depending on the requirements. “The current ‘one size fits all’ approach to healthcare fails to recognize the significant differences between the bodies and behaviors of different patients. This not only creates inefficiencies and cost overruns but also affects the quality of care provided. By personalizing the specific treatment to each patient, healthcare will become more affordable for patients and more profitable for providers due to increased efficiency,” adds Marchal.

Additionally, with the increasing usage of wearable and implanted devices, collecting personalized data to feed predictive models is becoming a reality. This allows healthcare providers to devise truly personalized treatment plans as well as to predict health problems before they occur. These practices foster the development of preventive medicines using statistical data and predictive analysis that will be able to detect and treat pathologies at a very early stage. According to the Avicenna Alliance, these techniques could benefit more than 50 percent of the clinical trials in the near future. While this “medical digital twin” concept might seem like science fiction, advanced technology is poised to improve the quality of life for people around the world. Marchal envisions the inevitable adoption of this in-silico approach offered by ANSYS, paving the way for virtual human laboratories to determine the uncertainties prevailing in medical sciences.

ANSYS [NASDAQ:ANSS] News

AVSimulation and Ansys Are Now Strategic Partners

ANSYS and AVSimulation have formed a strategic partnership with an aim to accelerate the development of secure and self-governing driving for automakers.

FREMONT, CA: The recently announced partnership between AVSimulation and ANSYS aims to facilitate autonomous vehicle validation and design through virtual testing, thereby ensuring millions of miles of test drive on roads within a single week. Read More

Medical Devices Special

Featured Vendors

  • ANSYS [NASDAQ:ANSS]: Modeling Human Body with Simulation Software
    ANSYS [NASDAQ:ANSS]: Modeling Human Body with Simulation Software
  • ADM Tronics Unlimited, Inc. [OTC:ADMT]: Transforming Care with Innovative Medical Technologies
    ADM Tronics Unlimited, Inc. [OTC:ADMT]: Transforming Care with Innovative Medical Technologies
  • DFI-ITOX:  High-Performance Medical Computing Devices
    DFI-ITOX: High-Performance Medical Computing Devices
  • OrthoSensor: Advanced Sensor-Assisted Technology for a Balanced Total Knee Replacement
    OrthoSensor: Advanced Sensor-Assisted Technology for a Balanced Total Knee Replacement

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Copyright © 2021 Embedded Advisor. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy.
follow on linkedin follow on twitter
This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

medical-devices.embeddedadvisor.com/vendor/ansys--nasdaqanss--modeling-human-body-with-simulation-software-cid-87-mid-8.html